These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35129463)

  • 41. KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinoma.
    Isohookana J; Haapasaari KM; Soini Y; Karihtala P
    Anticancer Res; 2018 Apr; 38(4):2295-2302. PubMed ID: 29599352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystic neoplasm mistaken for pancreatic pseudocyst.
    Civello IM; Frontera D; Viola G; Maria G; Crucitti F
    Hepatogastroenterology; 1996; 43(10):967-70. PubMed ID: 8884322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrence of a pancreatic cystic lymphangioma after diagnosis and complete drainage by endoscopic ultrasound with fine-needle aspiration.
    Mansour NM; Salyers WJ
    JOP; 2013 May; 14(3):280-2. PubMed ID: 23669480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of endoscopy in acute recurrent and chronic pancreatitis and pancreatic cancer.
    Jakobs R; Riemann JF
    Gastroenterol Clin North Am; 1999 Sep; 28(3):783-800, xii. PubMed ID: 10503150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
    Halle-Smith JM; Hall L; Daamen LA; Hodson J; Pande R; Young A; Jamieson NB; Lamarca A; van Santvoort HC; Molenaar IQ; Valle JW; Roberts KJ
    Eur J Surg Oncol; 2021 Sep; 47(9):2248-2255. PubMed ID: 34034941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.
    Okabayashi T; Nishimori I; Nishioka A; Yamashita K; Sugimoto T; Dabanaka K; Maeda H; Kohsaki T; Ogawa Y; Kobayashi M; Onishi S; Hanazaki K
    Oncol Rep; 2008 Sep; 20(3):651-6. PubMed ID: 18695919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does long-term survival exist in pancreatic adenocarcinoma?
    Zijlstra M; Bernards N; de Hingh IH; van de Wouw AJ; Goey SH; Jacobs EM; Lemmens VE; Creemers GJ
    Acta Oncol; 2016; 55(3):259-64. PubMed ID: 26559995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
    Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
    J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Local recurrence and multi-organ metastasis of primary retroperitoneal leiomyosarcoma in unusual locations after surgical resection.
    Lal H; Neyaz Z; Kapoor VK; Pottakkat B; Gupta P
    J Radiol Case Rep; 2011; 5(6):1-8. PubMed ID: 22470795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Impact of Socioeconomic Status, Surgical Resection and Type of Hospital on Survival in Patients with Pancreatic Cancer. A Population-Based Study in The Netherlands.
    van Roest MH; van der Aa MA; van der Geest LG; de Jong KP
    PLoS One; 2016; 11(11):e0166449. PubMed ID: 27832174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current and future therapies for advanced pancreatic cancer.
    Gupta R; Amanam I; Chung V
    J Surg Oncol; 2017 Jul; 116(1):25-34. PubMed ID: 28591939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of multicentre diagnostic workup in patients with pancreatic cancer on repeated diagnostic investigations, time-to-diagnosis and time-to-treatment: A nationwide analysis.
    Hopstaken JS; Vissers PAJ; Quispel R; de Vos-Geelen J; Brosens LAA; de Hingh IHJT; van der Geest LG; Besselink MG; van Laarhoven KJHM; Stommel MWJ;
    Eur J Surg Oncol; 2022 Oct; 48(10):2195-2201. PubMed ID: 35701256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer.
    Wilkowski R; Thoma M; Bruns C; Dühmke E; Heinemann V
    JOP; 2006 Jan; 7(1):34-40. PubMed ID: 16407616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Recurrent duodenal ulcer bleeding as the first manifestation of a solid pseudopapillary neoplasm of the pancreas with hepatic metastases].
    Schlitter AM; Konukiewitz B; Kleeff J; Klöppel G; Esposito I
    Dtsch Med Wochenschr; 2013 May; 138(20):1050-3. PubMed ID: 23670260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands.
    van der Geest LG; Besselink MG; van Gestel YR; Busch OR; de Hingh IH; de Jong KP; Molenaar IQ; Lemmens VE
    Acta Oncol; 2016; 55(3):278-85. PubMed ID: 26552841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive comparison of clinicopathological characteristics, treatment, and prognosis of borderline resectable pancreatic cancer according to tumor location.
    Takeda T; Sasaki T; Inoue Y; Mie T; Furukawa T; Kanata R; Kasuga A; Matsuyama M; Ozaka M; Takahashi Y; Saiura A; Sasahira N
    Pancreatology; 2020 Sep; 20(6):1123-1130. PubMed ID: 32753119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands.
    Genc CG; Klümpen HJ; van Oijen MGH; van Eijck CHJ; Nieveen van Dijkum EJM
    World J Surg; 2018 Feb; 42(2):490-497. PubMed ID: 29018912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment and present status of pancreatic cancer].
    Onoyama H; Kamigaki T; Yamamoto M; Saitoh Y
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2304-10. PubMed ID: 1463335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of isolated recurrence after surgery for pancreatic adenocarcinoma.
    Kim YI; Song KB; Lee YJ; Park KM; Hwang DW; Lee JH; Shin SH; Kwon JW; Ro JS; Kim SC
    Br J Surg; 2019 Jun; 106(7):898-909. PubMed ID: 31162655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Characterization and Treatment of Pancreatic Neuroendocrine Tumors.
    De Jesus-Acosta AMC
    Oncology (Williston Park); 2019 Dec; 33(12):. PubMed ID: 31914198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.